Terms: = Leukemia AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Clinical Outcome
2 results:
1. Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (iris).
Hughes TP; Hochhaus A; Branford S; Müller MC; Kaeda JS; Foroni L; Druker BJ; Guilhot F; Larson RA; O'Brien SG; Rudoltz MS; Mone M; Wehrle E; Modur V; Goldman JM; Radich JP;
Blood; 2010 Nov; 116(19):3758-65. PubMed ID: 20679528
[TBL] [Abstract] [Full Text] [Related]
2. Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases.
Cockerham GC; Hidayat AA; Bijwaard KE; Sheng ZM
Ophthalmology; 2000 Jan; 107(1):151-8. PubMed ID: 10647734
[TBL] [Abstract] [Full Text] [Related]
